The company's products combine cell regeneration technologies with proprietary growth factors and biocompatible scaffolds to restore injured or chronically damaged tissues to normal. ProChon has filed patent applications, licensed patents for core technologies and products, and has been granted patents in the United States, Europe, Israel and Australia. The company's R&D facility is located in Ness Ziona, Israel, while the executive management team is based in Woburn, Massachusetts. ProChon offers orthobiologic therapeutic solutions, including BioCart, an autologous cartilage regeneration system for the treatment of joint cartilage defects and injuries.